Sera Prognostics Q3 2023 Earnings Report
Key Takeaways
Sera Prognostics reported Q3 2023 revenue of $42,000, a decrease from $87,000 in the same period of 2022. The company's net loss was $7.2 million, an improvement compared to $10.7 million in Q3 2022. Management completed planned cost reduction activities to extend cash runway through most of 2027.
Permanent President and CEO and CFO appointments for Zhenya Lindgardt and Austin Aerts were approved.
Management team completed planned cost reduction activities to extend cash runway through most of 2027.
Scaling care coordination offering and providing it for institutional customers for women identified as high-risk for preterm birth using PreTRM test.
New high-low risk predictor product moved into next phase of market research in preparation for clinical validation.
Sera Prognostics
Sera Prognostics
Forward Guidance
The company is laying the groundwork for a reinvigorated commercial focus designed to cost-effectively target increased test adoption through institutional customer focus and care coordination program, and are exploring potential product and partnership pathways to expand commercial revenue.